0001562180-22-006259.txt : 20220822
0001562180-22-006259.hdr.sgml : 20220822
20220822190032
ACCESSION NUMBER: 0001562180-22-006259
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220819
FILED AS OF DATE: 20220822
DATE AS OF CHANGE: 20220822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Gregory
CENTRAL INDEX KEY: 0001329505
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 221184817
MAIL ADDRESS:
STREET 1: 4 A CHESHAM STREET
CITY: LONDON
STATE: X0
ZIP: SW1X8DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-08-19
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001329505
Bailey Gregory
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
true
false
false
false
Common Stock
2022-08-19
4
P
false
38000.00
148.0441
A
2583658.00
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $147.98 - $148.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
/s/ George Clark, Attorney-in-Fact
2022-08-22